SID 2026Abstract 1045
First-in-class potent and selective dual STAT1/3 inhibitors optimized for topical treatment of dermatologic inflammatory diseases
Moreno A, Vaswani R, Park D, Kim J, Cohen-Katsenelson K, Treiber D, Bifulco N, Smith P, Nirula A
SID Annual Meeting 2026Preclinical studiesChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Topical treatments
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.1076 · Not in PubMed: details from Crossref